High cholesterol is a major driver of heart disease. Statins, like Lipitor and Zocor, emerged as powerful antidotes starting ...

Merck said Saturday its new pill — a potential rival to Regeneron and Amgen — lowered stubbornly high cholesterol by almost ...

Amgen today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha® (evolocumab) achieved statistically significant and clinically meaningful reductions in ...

For some people with high cholesterol, making lifestyle changes and taking routine cholesterol-lowering statin medications may not be sufficient in helping them reach their target cholesterol levels.

GoodRx Holdings, Inc. ( GDRX) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx Third Quarter 2025 Earnings Call. As a ...

RevBio® announced today that TETRANITE, the company's first of its kind regenerative "bone glue" has been approved for a 20-patient pilot study to measure the biomaterial's safety and efficacy to ...

US markets closed sharply lower yesterday, with major indices erasing Wednesday’s gains to hit two-week lows. In the absence of proper employment data (due to the government shutdown), jobs numbers ...